Live Breaking News & Updates on Andream Divenere

Stay updated with breaking news from Andream divenere. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

The FINANCIAL - Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access


Share This
The FINANCIAL  In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the supply of affordable vaccines to address the pandemic.
The vaccine, NDV-HXP-S, can be stored at 2-8 degrees Celsius and is made in eggs, a method also used for flu vaccine manufacturing. These factors mean that affordable manufacturing capacity already exists in each of the countries involved with trials, The University of Texas at Austin notes. ....

New York , United States , Republic Of , Jorya Goldsmith , Jennifer Maynard , Jeffreym Schaub , Nicolev Johnson , Nianshuang Wang , Ching Lin Hsieh , Andream Divenere , Christyk Hjorth , Ilyaj Finkelstein , Jennifera Maynard , Adolfo Garcia Sastre , Peter Palese , Jason Mclellan , Ilya Finkelstein , Horacew Goldsmith , Kamyab Javanmardi , Chia Wei Chou , Che Kuo , Patricko Byrne , Florian Krammer , Daniel Wrapp , Jasons Mclellan , Vietnam Institute Of Vaccines ,